Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

USP1-dependent RPS16 protein stability drives growth and metastasis of human hepatocellular carcinoma cells
Yuning Liao, Zhenlong Shao, Yuan Liu, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

The role of ubiquitination and deubiquitination in tumor invasion and metastasis
Shuangze Han, Ruike Wang, Yangnan Zhang, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 6, pp. 2292-2303
Open Access | Times Cited: 121
PHGDH: a novel therapeutic target in cancer
Chae Min Lee, Yeseong Hwang, Minki Kim, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 7, pp. 1513-1522
Open Access | Times Cited: 13
USP1 promotes cholangiocarcinoma progression by deubiquitinating PARP1 to prevent its proteasomal degradation
Deng Yong Zhang, Yan Zhu, Qiong Wu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 10
Open Access | Times Cited: 18
HSP90β Impedes STUB1‐Induced Ubiquitination of YTHDF2 to Drive Sorafenib Resistance in Hepatocellular Carcinoma
Yuning Liao, Yuan Liu, Cuifu Yu, et al.
Advanced Science (2023) Vol. 10, Iss. 27
Open Access | Times Cited: 17
USP21 deubiquitinates and stabilizes HSP90 and ENO1 to promote aerobic glycolysis and proliferation in cholangiocarcinoma
Xiao Xu, Yananlan Chen, Shenye Shao, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 4, pp. 1492-1508
Open Access | Times Cited: 9
Inhibition of USP1 activates ER stress through Ubi-protein aggregation to induce autophagy and apoptosis in HCC
Longhao Wang, Tao Hu, Zhibo Shen, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 11
Open Access | Times Cited: 26
USP1 modulates hepatocellular carcinoma progression via the Hippo/TAZ axis
Dongyi Liu, Quanhui Li, Yifeng Zang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 4
Open Access | Times Cited: 16
Ubiquitin-specific peptidase 1: assessing its role in cancer therapy
Peng Huang, Yuhan Wang, Pengfei Zhang, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 2953-2966
Closed Access | Times Cited: 16
SNS-023 sensitizes hepatocellular carcinoma to sorafenib by inducing degradation of cancer drivers SIX1 and RPS16
Yuan Liu, Weiyao Kong, Cuifu Yu, et al.
Acta Pharmacologica Sinica (2022) Vol. 44, Iss. 4, pp. 853-864
Closed Access | Times Cited: 19
Inhibition of USP1 reverses the chemotherapy resistance through destabilization of MAX in the relapsed/refractory B-cell lymphoma
Xi-Ya Li, Jichuan Wu, Ping Liu, et al.
Leukemia (2022) Vol. 37, Iss. 1, pp. 164-177
Open Access | Times Cited: 19
ML323, a USP1 inhibitor triggers cell cycle arrest, apoptosis and autophagy in esophageal squamous cell carcinoma cells
Yaxin Sun, Beibei Sha, Wenjing Huang, et al.
APOPTOSIS (2022) Vol. 27, Iss. 7-8, pp. 545-560
Closed Access | Times Cited: 17
Ubiquitin specific peptidases and prostate cancer
Yunfei Guo, Shuaishuai Cui, Yuanyuan Chen, et al.
PeerJ (2023) Vol. 11, pp. e14799-e14799
Open Access | Times Cited: 10
USP32 deubiquitinase: cellular functions, regulatory mechanisms, and potential as a cancer therapy target
Shuang Li, Yang Song, Kexin Wang, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 10
The other side of the coin: protein deubiquitination by Ubiquitin-Specific Protease 1 in cancer progression and therapy
Xinlan Hu, Yan Wu, Mengmeng Yao, et al.
Future Medicinal Chemistry (2025) Vol. 17, Iss. 3, pp. 329-345
Closed Access
NRF1 Transcriptionally Regulates USP1-Mediated Deubiquitination of AURKA to Facilitate Osteosarcoma Progression
Hui Yang, G. J. Shang
Molecular Biotechnology (2025)
Closed Access
The role of USP1 deubiquitinase in the pathogenesis and therapy of cancer
Svitlana Antonenko, М.П. Завелевич, Г. Д. Телегеев
Acta Biochimica Polonica (2023)
Open Access | Times Cited: 9
Emerging roles of deubiquitinating enzymes in actin cytoskeleton and tumor metastasis
Ying Xue, Cong Xue, Wei Song
Cellular Oncology (2024) Vol. 47, Iss. 4, pp. 1071-1089
Closed Access | Times Cited: 3
Tumor-suppressive activities for pogo transposable element derived with KRAB domain via ribosome biogenesis restriction
Zhenbo Tu, Mahmoud A. Bassal, George W. Bell, et al.
Molecular Cell (2024) Vol. 84, Iss. 21, pp. 4209-4223.e6
Closed Access | Times Cited: 3
Research Progress of DUB Enzyme in Hepatocellular Carcinoma
Jie Zhao, Jinhui Guo, Yanan Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 14
ARV-771 Acts as an Inducer of Cell Cycle Arrest and Apoptosis to Suppress Hepatocellular Carcinoma Progression
Yuanfei Deng, Cuifu Yu, Lushi Chen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 13
Deubiquitinase USP1 regulates sarbecovirus ORF6 protein function
Wenying Gao, Liuli Wang, Wenzhe Cui, et al.
Journal of Virology (2023) Vol. 98, Iss. 1
Open Access | Times Cited: 8
MicroRNA let-7 Suppresses Influenza A Virus Infection by Targeting RPS16 and Enhancing Type I Interferon Response
Wenjiao Wu, Chao Wang, Xia Changliang, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 11
The P53–P21–RB1 pathway promotes BRD4 degradation in liver cancer through USP1
Neng Li, Erlei Zhang, Zhenyong Li, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 3, pp. 105707-105707
Open Access | Times Cited: 2
SENP3 mediates deSUMOylation of SIX1 to promote prostate cancer proliferation and migration
Zhenlong Shao, Shutong Liu, Wenshuang Sun, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 2
High Expression of G9a Induces Cisplatin Resistance in Hepatocellular Carcinoma.
Junhao Fu, Yu Min, Wenxia Xu, et al.
PubMed (2023) Vol. 25, Iss. 2, pp. 118-125
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top